Literature DB >> 1698817

Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis.

R M McCarron1, R J Fallis, D E McFarlin.   

Abstract

In order to assess T cell antigen specificities and class II restriction requirements during the course of chronic relapsing experimental allergic encephalomyelitis (CREAE), (SJL x PL)F1 mice were used as a model. EAE can be passively transferred in these mice by F1 T cells incubated with Ia-positive antigen-presenting cells (APC) from either parent SJL (H-2s) or PL (H-2u) and MBP fragments 89-169 or 1-37, respectively. T cells purified from F1 mice immunized with MBP fragment 1-37 were positively selected for I-Au-supported proliferation by culture in the presence of irradiated Iau-positive PL spleen cells as APC. I-As-supported proliferation and proliferation to residues 89-169 were not detected following selection. Adoptive transfer of this T cell line induced CREAE in naive recipient F1 mice and 2 weeks after the second attack of EAE recipient proliferative responses were measured. Recipient T cells proliferated to both fragment 1-37 and fragment 89-169. Moreover, proliferation was supported by I-As-positive as well as I-Au-positive macrophages. These findings demonstrate that T cells with novel epitope specificities and class II restriction requirements can be generated during the course of CREAE and suggest the possibility that such cells may be involved in the pathogenesis of this chronic autoimmune illness.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698817     DOI: 10.1016/0165-5728(90)90149-h

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  20 in total

Review 1.  Mechanisms of immune-mediated demyelinating disease of the central nervous system.

Authors:  D Baker; A N Davison
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

2.  Progression of relapsing-remitting demyelinating disease does not require increased TCR affinity or epitope spread.

Authors:  Anna E Kersh; Lindsay J Edwards; Brian D Evavold
Journal:  J Immunol       Date:  2014-09-29       Impact factor: 5.422

Review 3.  Oral tolerance.

Authors:  H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

4.  Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

Authors:  C P Genain; M H Nguyen; N L Letvin; R Pearl; R L Davis; M Adelman; M B Lees; C Linington; S L Hauser
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 5.  Experimental autoimmune uveitis: molecular mimicry and oral tolerance.

Authors:  V K Singh; K Nagaraju
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

6.  Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.

Authors:  E A Elliott; H I McFarland; S H Nye; R Cofiell; T M Wilson; J A Wilkins; S P Squinto; L A Matis; J P Mueller
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

7.  Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.

Authors:  E Meinl; F Weber; K Drexler; C Morelle; M Ott; G Saruhan-Direskeneli; N Goebels; B Ertl; G Jechart; G Giegerich
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene.

Authors:  Ming-Chao Zhong; Nicole Kerlero de Rosbo; Avraham Ben-Nun
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

9.  Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

Authors:  A Friedman; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

10.  Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.

Authors:  Bernadette Pöllinger; Gurumoorthy Krishnamoorthy; Kerstin Berer; Hans Lassmann; Michael R Bösl; Robert Dunn; Helena S Domingues; Andreas Holz; Florian C Kurschus; Hartmut Wekerle
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.